Literature DB >> 27509362

Enteral Nutrition and Acid-Suppressive Therapy in the PICU: Impact on the Risk of Ventilator-Associated Pneumonia.

Ben D Albert1, David Zurakowski, Lori J Bechard, Gregory P Priebe, Christopher P Duggan, Daren K Heyland, Nilesh M Mehta.   

Abstract

OBJECTIVE: Enteral nutrition has been implicated as a risk factor for ventilator-associated pneumonia. We explored the prevalence of ventilator-associated pneumonia and its association with clinical and nutrition-related therapies in mechanically ventilated children.
DESIGN: Prospective, multicenter, cohort study.
SETTING: Fifty-nine PICU in 15 countries. PATIENTS: Children less than 18 years old, mechanically ventilated for more than 48 hours.
INTERVENTIONS: None. Multivariable logistic regression to determine factors associated with ventilator-associated pneumonia. MEASUREMENTS AND MAJOR
RESULTS: Data are presented as median (interquartile range) or counts (%). We enrolled 1,245 subjects (45% women; 42% surgical), age 20 months (4-84 mo), and duration of mechanical ventilation 7 days (3-13 d). Culture-positive ventilator-associated pneumonia was diagnosed in 80 patients (6.4%); duration of mechanical ventilation for this subgroup was 17 days (8-39 d). Enteral nutrition was delivered in 985 patients (79%), initiated within 48 hours in 592 patients (60%), and via postpyloric route in 354 patients (36%). Acid-suppressive agents were used in 763 patients (61%). The duration of enteral nutrition (p = 0.21), route (gastric vs postpyloric) of delivery (p = 0.94), severity of illness (p = 0.17), and diagnostic category on admission (p = 0.31) were not associated with ventilator-associated pneumonia. After adjusting for enteral nutrition days, illness severity, and site, ventilator-associated pneumonia was significantly associated with mechanical ventilation more than 10 days (odds ratio, 3.7; 95% CI, 2.2-6.5; p < 0.001), PICU length of stay more than 10 days (odds ratio, 1.8; 95% CI, 1.1-3.1; p = 0.029), and the use of acid-suppressive medication (odds ratio, 2.0; 95% CI, 1.2-3.6; p = 0.011).
CONCLUSIONS: Ventilator-associated pneumonia was diagnosed in 6.5% of mechanically ventilated children in a heterogeneous multicenter cohort. We did not find a link between enteral nutrition duration or route of delivery and ventilator-associated pneumonia. In addition to duration of mechanical ventilation and length of PICU stay, the use of acid-suppressive therapy independently increased the likelihood of developing ventilator-associated pneumonia in this population. This association must be further explored in clinical trials.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27509362      PMCID: PMC5052100          DOI: 10.1097/PCC.0000000000000915

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.624


  28 in total

Review 1.  The effect of proton pump inhibitors on the human microbiota.

Authors:  B J Vesper; A Jawdi; K W Altman; G K Haines; L Tao; J A Radosevich
Journal:  Curr Drug Metab       Date:  2009-01       Impact factor: 3.731

2.  Ventilator-associated pneumonia in an Italian pediatric intensive care unit: a prospective study.

Authors:  Maria Francesca Patria; Giovanna Chidini; Ludovica Ughi; Cinzia Montani; Edi Prandi; Carlotta Galeone; Edoardo Calderini; Susanna Esposito
Journal:  World J Pediatr       Date:  2013-11-14       Impact factor: 2.764

3.  Early enteral nutrition is associated with lower mortality in critically ill children.

Authors:  Theresa A Mikhailov; Evelyn M Kuhn; Jennifer Manzi; Melissa Christensen; Maureen Collins; Ann-Marie Brown; Ronald Dechert; Matthew C Scanlon; Martin K Wakeham; Praveen S Goday
Journal:  JPEN J Parenter Enteral Nutr       Date:  2014-01-08       Impact factor: 4.016

Review 4.  Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors.

Authors:  F E Harrell; K L Lee; D B Mark
Journal:  Stat Med       Date:  1996-02-28       Impact factor: 2.373

5.  Use of Acid Suppression Medication is Associated With Risk for C. difficile Infection in Infants and Children: A Population-based Study.

Authors:  Daniel E Freedberg; Esi S Lamousé-Smith; Jenifer R Lightdale; Zhezhen Jin; Yu-Xiao Yang; Julian A Abrams
Journal:  Clin Infect Dis       Date:  2015-06-09       Impact factor: 9.079

Review 6.  Stress-induced ulcer bleeding in critically ill patients.

Authors:  Tauseef Ali; Richard F Harty
Journal:  Gastroenterol Clin North Am       Date:  2009-06       Impact factor: 3.806

7.  Nosocomial pneumonia risk and stress ulcer prophylaxis: a comparison of pantoprazole vs ranitidine in cardiothoracic surgery patients.

Authors:  Todd A Miano; Marc G Reichert; Timothy T Houle; Drew A MacGregor; Edward H Kincaid; David L Bowton
Journal:  Chest       Date:  2009-03-24       Impact factor: 9.410

8.  Acid-suppressive medication use and the risk for hospital-acquired pneumonia.

Authors:  Shoshana J Herzig; Michael D Howell; Long H Ngo; Edward R Marcantonio
Journal:  JAMA       Date:  2009-05-27       Impact factor: 56.272

9.  Study of ventilator-associated pneumonia in a pediatric intensive care unit.

Authors:  Pooja Balasubramanian; Milind S Tullu
Journal:  Indian J Pediatr       Date:  2014-05-14       Impact factor: 1.967

10.  Effects of ranitidine and pantoprazole on ventilator-associated pneumonia: a randomized double-blind clinical trial.

Authors:  Farshid Rahimi Bashar; Nahid Manuchehrian; Mojtaba Mahmoudabadi; Mohammad Reza Hajiesmaeili; Saadat Torabian
Journal:  Tanaffos       Date:  2013
View more
  4 in total

Review 1.  Future Directions and Molecular Basis of Ventilator Associated Pneumonia.

Authors:  Kubra Aykac; Yasemin Ozsurekci; Sevgen Tanir Basaranoglu
Journal:  Can Respir J       Date:  2017-10-15       Impact factor: 2.409

2.  Ventilator-associated pneumonia in PICU - how are we doing?

Authors:  L van Wyk; J T Applegate; S Salie
Journal:  South Afr J Crit Care       Date:  2022-08-05

3.  Need for a Randomized Controlled Trial of Stress Ulcer Prophylaxis in Critically Ill Children: A Canadian Survey.

Authors:  Mark Duffett; Karen Choong; Jennifer Foster; Elaine Gilfoyle; Jacques Lacroix; Deborah J Cook
Journal:  Can J Hosp Pharm       Date:  2017-08-31

4.  Stress ulcer prophylaxis versus placebo-a blinded randomized control trial to evaluate the safety of two strategies in critically ill infants with congenital heart disease (SUPPRESS-CHD).

Authors:  Kimberly I Mills; Ben D Albert; Lori J Bechard; Christopher P Duggan; Aditya Kaza; Seth Rakoff-Nahoum; Hera Vlamakis; Lynn A Sleeper; Jane W Newburger; Gregory P Priebe; Nilesh M Mehta
Journal:  Trials       Date:  2020-06-29       Impact factor: 2.728

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.